Clene (CLNN) Competitors

Organigram (NASDAQ:OGI) and Clene (NASDAQ:CLNN) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, dividends, profitability, media sentiment, valuation, institutional ownership, analyst recommendations, community ranking and earnings.

Does the media favor OGI or CLNN?

In the previous week, Organigram had 3 more articles in the media than Clene. MarketBeat recorded 4 mentions for Organigram and 1 mentions for Clene. Clene's average media sentiment score of 1.21 beat Organigram's score of 0.51 indicating that Clene is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Organigram	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Clene	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is OGI or CLNN more profitable?

Organigram has a net margin of -31.69% compared to Clene's net margin of -8,556.77%. Organigram's return on equity of -8.59% beat Clene's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Organigram	-31.69%	-8.59%	-6.54%
Clene	-8,556.77%	-1,106.30%	-85.11%

Do analysts prefer OGI or CLNN?

Clene has a consensus target price of $55.25, indicating a potential upside of 1,147.18%. Given Clene's stronger consensus rating and higher probable upside, analysts clearly believe Clene is more favorable than Organigram.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Organigram	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Clene	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	3.20

Do institutionals and insiders hold more shares of OGI or CLNN?

34.6% of Organigram shares are owned by institutional investors. Comparatively, 23.3% of Clene shares are owned by institutional investors. 0.1% of Organigram shares are owned by insiders. Comparatively, 25.1% of Clene shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Which has more risk and volatility, OGI or CLNN?

Organigram has a beta of 1, indicating that its stock price has a similar volatility profile to the S&P 500.Comparatively, Clene has a beta of 0.24, indicating that its stock price is 76% less volatile than the S&P 500.

Which has stronger earnings & valuation, OGI or CLNN?

Organigram has higher revenue and earnings than Clene. Organigram is trading at a lower price-to-earnings ratio than Clene, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Organigram	$117.47M	1.41	-$33.39M	-$0.38	-3.45
Clene	$650K	56.77	-$49.50M	-$5.28	-0.84

Does the MarketBeat Community favor OGI or CLNN?

Organigram received 125 more outperform votes than Clene when rated by MarketBeat users. However, 79.35% of users gave Clene an outperform vote while only 70.71% of users gave Organigram an outperform vote.

Company	Underperform	Outperform
Organigram	Outperform Votes 198 70.71%	Underperform Votes 82 29.29%
Clene	Outperform Votes 73 79.35%	Underperform Votes 19 20.65%

Summary

Organigram beats Clene on 10 of the 19 factors compared between the two stocks.